With pharma still struggling in Alzheimer’s, health tech companies want a swing
(By Katie Palmer for ST A T) In the wake of the first Alzheimer’s drug approval in nearly two decades,
Read More
Part D/Prescription Drugs
Do I really need another booster? The answer depends on age, risk and timing
(By Maria Godoy, Allison Aubrey and Jane Greenhalgh for NPR) The Biden administration has given the go-ahead for another COVID
Read MoreOut-of-pocket spending on insulin among people with private insurance
(By Krutika Amin, Gary Claxton, Matthew Rae, and Cynthia Cox for Kaiser Family Foundation published March 24, 2022) The Build
Read MoreThe FDA is expected to authorize 2nd boosters for people 50 and up
(By Rob Stein and Jane Greenhalgh for NPR) Anyone 50 years and older could soon be eligible for a second
Read MoreTips on reviewing your Medicare Advantage plan
Many people switch to Medicare Advantage during the fall Medicare Annual Enrollment Period, not fully understanding how the plans work.
Read MoreDon’t wait: Medicare Advantage Open Enrollment ends March 31
(Source - www.medicare.gov/blog) Did you know that if you’re unhappy with your Medicare Advantage Plan (Medicare Part C), you have
Read MorePayer organizations respond to CMS’ Medicare Advantage, Part D proposed rule
(By Georgina Gonzalez for Becker’s Hospital Review ) America’s Health Insurance Plans and the Alliance of Community Health Plans have
Read MoreWomen see more adverse events with chemotherapy and newer cancer treatments, study finds
(By Marcus A. Banks for ST A T) When Crystal Ortner was diagnosed with stage 4 colon cancer, her doctors
Read MorePatients Divided Over Alzheimer’s Drug: Is It a ‘Risk I’m Willing to Take’ or Just a ‘Magic Pill’?
(By Judith Graham for Kaiser Health News) If you listen to the nation’s largest Alzheimer’s disease advocacy organizations, you might
Read MoreSacklers agree to $6 billion Purdue bankruptcy settlement over opioid crisis
(By Ed Silverman for ST A T) The Sackler family members who own Purdue Pharma have agreed to pay up
Read More